Affinium Parmaceuticals News
2010
-
APRIL 9, 2010
Affinium Pharmaceuticals, Ltd. Announces the Initiation of a Phase I Clinical Trial Using an Optimized Oral Formulation of AFN-1252, its Novel Anti-staphylococcal Antibiotic Click for PDF version (PDF 23KB)
2008
-
DECEMBER 8, 2008
Affinium Pharmaceuticals, Ltd. Announces the Initiation of a Phase I Clinical Trial for the New Tablet Form of AFN-1252, its Novel Anti-staphylococcal Antibiotic Click for PDF version (PDF 18KB)
-
MARCH 4, 2008
Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic Click for PDF version (PDF 18KB)
2007
-
APRIL 2, 2007
Affinium Pharmaceuticals Welcomes Dr. Barry Hafkin as Chief Medical Officer Click for PDF version (PDF 18KB)
-
MARCH 26, 2007
Affinium Pharmaceuticals Closes US$18 Million Series A to Advance Clinical Development of Novel Antibacterial Compound Click for PDF version (PDF 17KB)
-
JANUARY 4, 2007
Affinium Pharmaceuticals Awarded US$4.8 Million Biodefense Research Contract by United States Department of Defense/DTRA Click for PDF version (PDF 19KB)
Duo an num quam fuisset sadipscing, elit animal doc endi enum num ut.